Ke Hua Bio (002022) said on the interactive platform that the company's main business is in vitro diagnosis, and there is no vaccine business.
Shanghai Ke Hua Bio-pharmaceutical Co., Ltd. was established atNo. 1995- 12-22, with the legal representative of Tang Weiguo, the registered capital of 33 147725 yuan, and the enterprise address is located at Qinzhou North Road 1 189, and the industry is pharmaceutical manufacturing. The business scope includes: production and sales of erythropoietin (EPO), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin (IL), interferon (IFN) and PRO-UK, production of hepatitis B nucleic acid therapeutic vaccine (DNA vaccine) and sales of self-produced products (those involving licensed operation are licensed to operate). Shanghai Ke Hua Biopharmaceutical Co., Ltd. is currently in the process of cancellation.